Innoviva, Inc.
DE ˙ DB ˙ US45781M1018
19,20 € ↑0,70 (3,78%)
2026-06-04
AKTIENPREIS
SecurityDE:HVE / Innoviva, Inc.
InstitutionInvesco Ltd.
Latest Disclosed Ownership904,282 shares
Latest Disclosed Value $ 21,069,771
Invesco Ltd. reports 8.60% increase in ownership of HVE / Innoviva, Inc.

On May 12, 2026 - Invesco Ltd. filed a 13F-HR form disclosing ownership of 904,282 shares of Innoviva, Inc. (DE:HVE) valued at $18,085,640 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 19, 2026 disclosing 832,635 shares of Innoviva, Inc.. This represents a change in shares of 8.60% during the quarter. The current value of the position is $17,362,214 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F INNOVIVA COM 45781M101 904,282 71,647 8.60 21,070 26.59 0.0032
2026-02-19 2025-12-31 13F INNOVIVA COM 45781M101 832,635 67,069 8.76 16,644 19.13 0.0026
2025-11-13 2025-09-30 13F INNOVIVA COM 45781M101 765,566 28,245 3.83 13,972 -5.68 0.0022
2025-08-13 2025-06-30 13F INNOVIVA COM 45781M101 737,321 -85,488 -10.39 14,813 -0.70 0.0025
2025-05-12 2025-03-31 13F INNOVIVA COM 45781M101 822,809 -229,070 -21.78 14,918 -18.26 0.0028
2025-02-13 2024-12-31 13F INNOVIVA COM 45781M101 1,051,879 -398,882 -27.49 18,250 -34.85 0.0034
2024-11-12 2024-09-30 13F INNOVIVA COM 45781M101 1,450,761 -111,871 -7.16 28,014 9.31 0.0054
2024-08-13 2024-06-30 13F INNOVIVA COM 45781M101 1,562,632 299,195 23.68 25,627 33.10 0.0054
2024-05-14 2024-03-31 13F INNOVIVA COM 45781M101 1,263,437 108,465 9.39 19,255 3.94 0.0041
2024-02-13 2023-12-31 13F INNOVIVA COM 45781M101 1,154,972 492,994 74.47 18,526 115.43 0.0044
2023-11-13 2023-09-30 13F INNOVIVA COM 45781M101 661,978 235,330 55.16 8,599 58.33 0.0023
2023-08-11 2023-06-30 13F INNOVIVA COM 45781M101 426,648 -65,449 -13.30 5,431 -1.90 0.0014
2023-05-12 2023-03-31 13F INNOVIVA COM 45781M101 492,097 -70,163 -12.48 5,536 -25.68 0.0015
2023-02-13 2022-12-31 13F INNOVIVA COM 45781M101 562,260 23,411 4.34 7,450 19.05 0.0022
2022-11-14 2022-09-30 13F INNOVIVA COM 45781M101 538,849 -678,037 -55.72 6,257 -65.17 0.0020
2022-08-15 2022-06-30 13F INNOVIVA COM 45781M101 1,216,886 -91,441 -6.99 17,962 -29.05 0.0054
2022-05-16 2022-03-31 13F INNOVIVA COM 45781M101 1,308,327 669,799 104.90 25,315 129.82 0.0065
2022-02-14 2021-12-31 13F INNOVIVA COM 45781M101 638,528 177,540 38.51 11,015 43.00 0.0027
2021-11-15 2021-09-30 13F INNOVIVA COM 45781M101 460,988 -1,790,928 -79.53 7,703 -74.49 0.0020
2021-08-17 2021-06-30 13F INNOVIVA COM 45781M101 2,251,916 -216,963 -8.79 30,199 2.36 0.0074
2021-05-17 2021-03-31 13F INNOVIVA COM 45781M101 2,468,879 -51,687 -2.05 29,503 -5.53 0.0079
2021-02-16 2020-12-31 13F INNOVIVA COM 45781M101 2,520,566 171,451 7.30 31,230 27.21 0.0091
2020-11-16 2020-09-30 13F INNOVIVA COM 45781M101 2,349,115 972,506 70.65 24,549 27.56 0.0083
2020-08-14 2020-06-30 13F INNOVIVA COM 45781M101 1,376,609 -123,032 -8.20 19,245 9.12 0.0069
2020-05-15 2020-03-31 13F INNOVIVA COM 45781M101 1,499,641 -634,259 -29.72 17,636 -41.63 0.0074
2020-02-14 2019-12-31 13F INNOVIVA COM 45781M101 2,133,900 398,254 22.95 30,216 65.17 0.0094
2019-11-14 2019-09-30 13F INNOVIVA COM 45781M101 1,735,646 -75,183 -4.15 18,294 -30.62 0.0048
2019-08-14 2019-06-30 13F/A-1 INNOVIVA COM 45781M101 1,810,829 -309,648 -14.60 26,367 -11.37 0.0068
2019-08-14 2019-06-30 13F INNOVIVA COM 45781M101 1,810,829 -2,083,543 26,367
2019-05-15 2019-03-31 13F INNOVIVA COM 45781M101 2,120,477 -59,454 -2.73 29,751 -21.79 0.0100
2019-02-14 2018-12-31 13F INNOVIVA COM 45781M101 2,179,931 -636,077 -22.59 38,040 -11.36 0.0146
2018-11-14 2018-09-30 13F INNOVIVA COM 45781M101 2,816,008 561,298 24.89 42,915 37.93 0.0135
2018-08-14 2018-06-30 13F INNOVIVA COM 45781M101 2,254,710 582,111 34.80 31,114 11.60 0.0103
2018-05-15 2018-03-31 13F INNOVIVA COM 45781M101 1,672,599 -324,401 -16.24 27,881 -1.61 0.0104
2018-02-14 2017-12-31 13F INNOVIVA COM 45781M101 1,997,000 -143,159 -6.69 28,338 -6.22 0.0102
2017-11-14 2017-09-30 13F INNOVIVA COM 45781M101 2,140,159 -101,245 -4.52 30,219 5.33 0.0112
2017-08-14 2017-06-30 13F INNOVIVA COM 45781M101 2,241,404 1,329,982 145.92 28,691 127.62 0.0089
2017-05-15 2017-03-31 13F INNOVIVA COM 45781M101 911,422 26,760 3.02 12,605 33.16 0.0041
2017-02-14 2016-12-31 13F INNOVIVA COM 45781M101 884,662 155,935 21.40 9,466 18.19 0.0032
2016-11-14 2016-09-30 13F INNOVIVA COM 45781M101 728,727 -133,239 -15.46 8,009 -11.76 0.0028
2016-08-15 2016-06-30 13F INNOVIVA COM 45781M101 861,966 230,034 36.40 9,076 14.06 0.0033
2016-05-16 2016-03-31 13F INNOVIVA COM 45781M101 631,932 -623,615 -49.67 7,957 -39.87 0.0032
2016-02-16 2015-12-31 13F THERAVANCE COM 88338T104 1,255,547 264,617 26.70 13,233 85.99 0.0053
2015-11-16 2015-09-30 13F THERAVANCE COM 88338T104 990,930 990,653 357,636.46 7,115 142,200.00 0.0030
2015-08-14 2015-06-30 13F THERAVANCE COMMON 88338T104 277 -798,900 -99.97 5 -99.96 0.0000
2015-05-15 2015-03-31 13F THERAVANCE COMMON 88338T104 799,177 799,177 0.00 12,563 0.0049
2014-08-14 2014-06-30 13F THERAVANCE COMMON 88338T104 0 -325,013 -100.00 0 -100.00
2014-05-15 2014-03-31 13F THERAVANCE COMMON 88338T104 325,013 303,893 1,438.89 10,056 1,235.46 0.0041
2014-02-13 2013-12-31 13F THERAVANCE COMMON 88338T104 21,120 3,410 19.25 753 4.01 0.0003
2013-11-13 2013-09-30 13F THERAVANCE COMMON 88338T104 17,710 530 3.08 724 9.37 0.0003
2013-08-14 2013-06-30 13F THERAVANCE COMMON 88338T104 17,180 17,180 662 0.0003
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.